Jan 16, 2023
Asia
The new article highlights the key points related to reporting adverse events associated with in vitro diagnostic medical devices and also describes the applicable reporting timelines. Table of Contents The Health Sciences Authority (HSA), Singapore’s regulatory...
Read More
Dec 9, 2022
Asia
The article provides an overview of the regulatory requirements in the sphere of adverse event reporting. Table of Contents The Health Sciences Authority (HSA), a Singapore’s regulatory agency in the sphere of healthcare products, has published a guidance document...
Read More
Dec 7, 2022
Asia
The new article covers the aspects related to the device-specific advertising requirements, as well as to the corrective measures to be taken with respect to non-compliances identified. Table of Contents The Health Sciences Authority (HSA), a Singapore’s regulatory...
Read More
Nov 30, 2022
Asia
The new article describes in detail the main principles to be followed when advertising medical devices in Singapore. Table of Contents The Health Sciences Authority (HSA), Singapore’s regulator agency in the sphere of healthcare products, has published a guidance...
Read More
Nov 17, 2022
Asia
The article provides an overview of the Singaporean regulatory requirements for advertising medical devices marketed in the country. Table of Contents The Health Sciences Authority (HSA), Singapore’s regulatory agency in the sphere of healthcare products, has...
Read More